Novobiocin inhibits vaccinia virus replication by blocking virus assembly

Virology

Volumn 235, Issue 1, 1997, Pages 129-137

  Sekiguchi, Joann ^a   Shuman, Stewart ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N1 ISONICOTINOYL N2 (4 CHLORO 3 METHYLBENZOYL)HYDRAZINE; NOVOBIOCIN; RIFAMPICIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SYNTHESIS; VACCINIA VIRUS; VIRUS ASSEMBLY; VIRUS REPLICATION;

VACCINIA; VACCINIA VIRUS;

EID: 0030801224     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8684     Document Type: Article

References (48)

1. r. Virology. 156:1987;138-145.
2. Baroudy B. M., Venkatesan S., Moss B. Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain. Cell. 28:1982;315-324.
3. Broyles S. S., Moss B. Sedimentation of an RNA polymerase complex from vaccinia specifically initiates and terminates transcription. Mol. Cell. Biol. 7:1987;7-14.
4. Condit R. C., Niles E. G. Orthopoxvirus genetics. Curr. Top. Microbiol. Immunol. 163:1990;1-39.
5. Condit R. C., Easterly R., Pacha R. F., Fathi Z., Meis R. A vaccinia virus isatin-β-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase. Virology. 185:1991;857-861.
6. Dales S., Milanovitch V., Pogo B. G. T., Weintraub S. B., Huima T., Wilton S., McFadden G. Biogenesis of vaccinia: Isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology. 84:1978;403-428.
7. DeLange A. M., Reddy M., Scraba D., Upton C., McFadden G. Replication and resolution of cloned poxvirus telomeresin vivo. J. Virol. 59:1986;249-259.
8. Dyster L. M., Niles E. G. Genetic and biochemical characterization of vaccinia virus genes D2L and D3R which encode virion structural proteins. Virology. 182:1991;455-467.
9. Ericsson M., Cudmore S., Shuman S., Condit R., Griffiths G., Locker J. K. Characterization ofts. J. Virol. 69:1995;7072-7086.
10. Fogelsong P. D., Bauer W. R. Effects of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase. J. Virol. 49:1984;1-8.
11. Fox G., Popanda O., Edler L., Thielmann H. W. Preferential inhibition of DNA polymerases alpha, delta, and epsilon from Novikoff hepatoma cells by inhibitors of cell proliferation. J. Cancer Res. Clin. Oncol. 122:1996;78-94.
12. Gottlieb S. L., Myskowski P. L. Molluscum contagiosum. Int. J. Dermatol. 33:1994;453-461.
13. Ikeda S., Yazawa M., Nishimura C. Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative. Antiviral Res. 8:1987;103-113.
14. Kane E. M., Shuman S. Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component. J. Virol. 67:1993;2689-2698.
15. Maxwell A. The interaction between coumarin drugs and DNA gyrase. Mol. Microbiol. 9:1993;681-686.
16. Meis R. J., Condit R. C. Genetic and molecular biological characterization of a vaccinia virus gene which renders the virus dependent on isatin-β-thiosemicarbazone (IBT). Virology. 182:1991;442-454.
17. Merchlinsky M. Resolution of poxvirus telomeres: Processing of vaccinia concatamer junctions by conservative strand exchange. J. Virol. 64:1990;3437-3446.
18. Merchlinsky M., Garon C. F., Moss B. Molecular cloning and sequence of the concatemer junction from vaccinia virus replicative DNA. J. Mol. Biol. 199:1988;399-413.
19. Merchlinsky M., Moss B. Resolution of linear minichromosomes with hairpin ends from circular plasmids containing vaccinia virus concatamer junctions. Cell. 45:1986;879-884.
20. Merchlinsky M., Moss B. Resolution of vaccinia virus DNA concatamer junctions requires late gene expression. J. Virol. 63:1989;1595-1603.
21. Morgan C. Vaccinia virus reexamined: Development and release. Virology. 73:1976;43-58.
22. Moss B. Poxviridae: The viruses and their replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 2637-2671.
23. Palu G., Meloni G. A., von Berger J., Masotti L. On the complex nature of the antiviral activity of coumermycin A1: Its interference with the replication of herpes simplex virus type 1. Antiviral Res. 6:1986;19-32.
24. Payne L. G., Kristensson K. Mechanism of vaccinia virus release and its specific inhibition byNN. J. Virol. 32:1979;614-622.
25. Ravanello M. P., Hruby D. E. Conditional lethal expression of the vaccinia virus L1R myristylated protein reveals a role in virion assembly. J. Virol. 68:1994;6401-6410.
26. Rempel R. E., Anderson M. K., Evans E., Traktman P. Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J. Virol. 64:1990;574-583.
27. Rodriguez D., Esteban M., Rodriguez J. R. Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J. Virol. 69:1995;4640-4648.
28. Rodriguez D., Esteban M., Rodriguez J. R. Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J. Virol. 70:1996;7641-7653.
29. Rodriguez J. R., Risco C., Carrascosa J. L., Esteban M., Rodriguez D. Characterization of early stages in vaccinia virus membrane biogenesis: Implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J. Virol. 71:1997;1821-1833.
30. r. J. Virol. 65:1991;3435-3442.
31. Sekiguchi J., Stivers J. T., Mildvan A. S., Shuman S. Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin. J. Biol. Chem. 271:1996a;2313-2322.
32. Sekiguchi J., Seeman N. C., Shuman S. Resolution of Holliday junctions by eukaryotic DNA topoisomerase I. Proc. Natl. Acad. Sci. USA. 93:1996b;785-789.
33. Shaffer R., Traktman P. Vaccinia virus encapsidates a novel topoisomerase with the properties of a eukaryotic type I enzyme. J. Biol. Chem. 262:1987;9309-9315.
34. Shuman S. Vaccinia DNA ligase: Specificity, fidelity, and inhibition. Biochemistry. 34:1995;16138-16147.
35. Shuman S., Golder M., Moss B. Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: Evidence that the gene is essential for virus growth. Virology. 170:1989;302-306.
36. Sodeik B., Doms R. W., Ericsson M., Hiller G., Machamer C. E., van't Hof W., van Meer G., Moss B., Griffiths G. Assembly of vaccinia virus: Role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J. Cell. Biol. 121:1993;521-541.
37. Sodeik B., Griffiths G., Ericsson M., Moss B., Doms R. W. Assembly of vaccinia virus: Effects of rifampin on the intracellular distribution of viral protein p65. J. Virol. 68:1994;1103-1114.
38. Spivack J. G., O'Boyle D. R., Fraser N. W. Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice. J. Virol. 61:1987;3288-3291.
39. Takahashi T., Oie M., Ichihashi Y. N-Terminal amino acid sequences of vaccinia virus structural proteins. Virology. 202:1994;844-852.
40. Tartaglia J., Piccini A., Paoletti E. Vaccinia virus rifampicin-resistance locus specifies a late 63,000 Da gene product. Virology. 150:1986;45-54.
41. Traktman P., Caligiuri A., Jesty S. A., Liu K., Sankar U. Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J. Virol. 69:1995;6581-6587.
42. VanSlyke J. K., Franke C. A., Hruby D. E. Proteolytic maturation of vaccinia virus core proteins: Identification of a conserved motif at the N termini of the 4b and 25K virion proteins. J. Gen. Virol. 72:1991a;411-416.
43. VanSlyke J. K., Whitehead S. S., Wilson E. M., Hruby D. E. The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: A degenerate conserved cleavage motif within core proteins. Virology. 183:1991b;467-478.
44. Wang S., Shuman S. Vaccina virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J. Virol. 69:1995;6376-6388.
45. Webb M. L., Jacob S. T. Inhibition of RNA polymerase I directed transcription by novobiocin: Potential use of novobiocin as a general inhibitor of eukaryotic transcription initiation. J. Biol. Chem. 263:1988;4745-4748.
46. Wolffe E. J., Moore D. M., Peters P. J., Moss B. Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. J. Virol. 70:1996;2797-2808.
47. Zhang Y., Moss B. Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by theEscherichia coli. J. Virol. 65:1991;6101-6110.
48. Zhang Y., Moss B. Immature viral particle formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampin. Virology. 187:1992;643-653.